Spots Global Cancer Trial Database for cannabis
Every month we try and update this database with for cannabis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes | NCT04988490 | Post-Surgical P... Post-Surgical C... Cancer Cannabis Use | 21 Years - | University of Colorado, Denver | ||
Real World Evidence on the Use of Medical Cannabis in Pediatrics | NCT05863910 | Cancer Epilepsy Neurodevelopmen... | Medical Cannabi... | 3 Years - 17 Years | University of Manitoba | |
CANnabinoids in Pediatric ONCology | NCT05754840 | Childhood Cance... Cancer | MPL-001 MPL-005 MPL-009 | 4 Years - 18 Years | University of Manitoba | |
CANnabinoids in Pediatric ONCology | NCT05754840 | Childhood Cance... Cancer | MPL-001 MPL-005 MPL-009 | 4 Years - 18 Years | University of Manitoba | |
Cannabis Oil for Pain Effectiveness | NCT03522467 | Cancer Chronic Pain | MRCP001 | 25 Years - 70 Years | Aurora Cannabis Inc | |
Cannabis Oil for Pain Effectiveness | NCT03522467 | Cancer Chronic Pain | MRCP001 | 25 Years - 70 Years | Aurora Cannabis Inc | |
Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma | NCT03246113 | Glioblastoma | Cannabis Temozolomide Radiation Thera... | 21 Years - 70 Years | New York State Psychiatric Institute | |
Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes | NCT04988490 | Post-Surgical P... Post-Surgical C... Cancer Cannabis Use | 21 Years - | University of Colorado, Denver | ||
Real World Evidence on the Use of Medical Cannabis in Pediatrics | NCT05863910 | Cancer Epilepsy Neurodevelopmen... | Medical Cannabi... | 3 Years - 17 Years | University of Manitoba | |
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use. | NCT01983267 | 1- Cancer Patie... 2- Use of Canna... | cannabis | 18 Years - 120 Years | Rambam Health Care Campus | |
CANnabinoids in Pediatric ONCology | NCT05754840 | Childhood Cance... Cancer | MPL-001 MPL-005 MPL-009 | 4 Years - 18 Years | University of Manitoba | |
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use. | NCT01983267 | 1- Cancer Patie... 2- Use of Canna... | cannabis | 18 Years - 120 Years | Rambam Health Care Campus | |
Cannabis Use in Cancer Patients | NCT03617692 | Solid Tumor, Ad... | 21 Years - 100 Years | University of Colorado, Denver | ||
Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma | NCT03246113 | Glioblastoma | Cannabis Temozolomide Radiation Thera... | 21 Years - 70 Years | New York State Psychiatric Institute | |
Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use. | NCT01983267 | 1- Cancer Patie... 2- Use of Canna... | cannabis | 18 Years - 120 Years | Rambam Health Care Campus | |
Cannabis For Cancer-Related Symptoms | NCT03948074 | Pain Nausea Anxiety Sleep Disturban... | Cannabis | 19 Years - | British Columbia Cancer Agency |